﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Advanced Pharmaceutical Bulletin</JournalTitle>
      <Issn>2228-5881</Issn>
      <Volume>6</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2016</Year>
        <Month>03</Month>
        <DAY>17</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>The Effects of Cetirizine on P-glycoprotein Expression and Function In vitro and In situ</ArticleTitle>
    <FirstPage>111</FirstPage>
    <LastPage>118</LastPage>
    <ELocationID EIdType="doi">10.15171/apb.2016.017</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mehran</FirstName>
        <LastName>Mesgari Abbasi</LastName>
      </Author>
      <Author>
        <FirstName>Hadi</FirstName>
        <LastName>Valizadeh</LastName>
      </Author>
      <Author>
        <FirstName>Hamed</FirstName>
        <LastName>Hamishekar</LastName>
      </Author>
      <Author>
        <FirstName>Leila</FirstName>
        <LastName>Mohammadnejad</LastName>
      </Author>
      <Author>
        <FirstName>Parvin</FirstName>
        <LastName>Zakeri-Milani</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.15171/apb.2016.017</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>12</Month>
        <Day>31</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2016</Year>
        <Month>03</Month>
        <Day>09</Day>
      </PubDate>
    </History>
    <Abstract>Purpose: P-glycoprotein (P-gp) plays a major role in oral absorption of drugs. Induction or inhibition of P-gp by drugs contributes to variability of its transport activity and often results in clinically relevant drug-drug interactions. The purpose of this study was to investigate the effect of cetirizine, a second generation H1 antihistamine, on P-gp function and expression in vitro and in situ. Methods: The in-vitro rhodamin-123 (Rho123) efflux assay in Caco-2 cells was used to study the effect of cetirizine on P-gp function. Western blot analysis was used for surveying the effect of cetirizine on expression of P-gp in Caco-2 cells. Rat in situ single-pass intestinal permeability technique was used to calculate the intestinal permeability of a known P-gp substrate (digoxin) in the presence of cetirizine. The amounts of digoxin and cetirizine in intestinal perfusion samples were analyzed using a HPLC method. Results: The results showed significant increase in Rho123 uptake (P &lt; 0.05) and also P-gp band intensity decrease in cetirizine-treated cells in vitro. Furthermore the intestinal permeability of digoxin was also increased significantly in the presence of cetirizine (P &lt; 0.01). Conclusion: Therefore it is concluded that cetirizine is a P-gp inhibitor and this should be considered in co administration of cetrizine with other P-gp substrate drugs. Further investigations are required to confirm our results and to determine the mechanism underlying P-gp inhibition by cetirizine.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Cetirizine</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Digoxin</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Intestinal permeability</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">P-glycoprotein</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>